Nutrition Beverage Tolerance Study
1 other identifier
interventional
121
1 country
1
Brief Summary
To evaluate the sensations experienced by subjects consuming a nutritional beverage.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_2
Started Oct 2011
Shorter than P25 for phase_2
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2011
CompletedFirst Submitted
Initial submission to the registry
November 1, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2011
CompletedFirst Posted
Study publicly available on registry
November 3, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2011
CompletedMay 1, 2012
April 1, 2012
1 month
November 1, 2011
April 30, 2012
Conditions
Outcome Measures
Primary Outcomes (1)
Proportion of subjects experiencing neurologic adverse event(s)
2-3 weeks
Secondary Outcomes (1)
Proportion of subjects experiencing any adverse event(s).
2-3 Weeks
Study Arms (3)
Nutritional Beverage #2
EXPERIMENTALNutritional Beverage with an amino acid Oral 237 ml
Nutritional Beverage #3
EXPERIMENTALNutritional Beverage with an amino acid Oral 237 ml
Nutritional Beverage #1
PLACEBO COMPARATORNutritional Beverage Oral 237 ml
Interventions
Eligibility Criteria
You may qualify if:
- Subject ≥ 45 years of age.
- If female, subject is either postmenopausal for at least 1 year or surgically sterile
- Subject reports that he/she has not participated in a research study in the last three months.
You may not qualify if:
- Subject has active metabolic or endocrine disease
- Subject has an autoimmune disorder
- Subject has a disorder of gastrointestinal tract or any gastrointestinal surgery in past 12 months.
- Subject has food allergy, celiac disease or intolerance to any of the ingredients in the study products
- Subject reports history of parasthesia; and/or is currently taking medication/dietary supplements/substances that may cause parasthesia for 4 weeks prior to screening
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Abbott Nutritionlead
Study Sites (1)
The National Food Lab
Livermore, California, 94551, United States
Study Officials
- STUDY CHAIR
Vikkie Mustad, PhD
Abbott
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 1, 2011
First Posted
November 3, 2011
Study Start
October 1, 2011
Primary Completion
November 1, 2011
Study Completion
December 1, 2011
Last Updated
May 1, 2012
Record last verified: 2012-04